Royal Bafokeng Platinum Ltd
F:7BF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royal Bafokeng Platinum Ltd
F:7BF
|
ZA |
|
C
|
China State Construction International Holdings Ltd
XMUN:C4S1
|
HK |
|
Alexandria Group Oyj
F:3ZL
|
FI |
|
R
|
Range Resources Corp
DUS:RAX
|
US |
|
Outlook Therapeutics Inc
F:41O
|
US |
|
China State Construction International Holdings Ltd
OTC:CCOHF
|
HK |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
M
|
Maersk Drilling A/S
F:72D
|
DK |
|
C
|
Country Garden Services Holdings Co Ltd
OTC:CTRGF
|
CN |
|
W
|
Watsco Inc
XMUN:WC3
|
US |
|
Homology Medicines Inc
NASDAQ:QTTB
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7BF's stock price target?
Not Available
7BF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Royal Bafokeng Platinum Ltd?
Projected CAGR
0%
Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Royal Bafokeng Platinum Ltd?
Projected CAGR
-10%
Over the last 8 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 3 years is -10%.